NCT02405078
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,099 public trials
2,041 recruiting studies
Lymphoproliferative Disorders trial results
NCT01586455
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adrenal Gland Diseases, +84 more
- Locations
-
- Children's Hospital Colorado Denver, Colorado, United States
- New York Medical College Valhalla, New York, United States
- University of Utah Salt Lake City, Utah, United States
NCT01842672
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +26 more
- Locations
-
- New York Medical College Valhalla, New York, United States
- Levine Children's Hospital Charlotte, North Carolina, United States
NCT01380145
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- New York University School of Medicine New York, United States
- Mount Sinai Hospital New York, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Completed
Treatment for Advanced B-Cell Lymphoma
NCT01859819
- Conditions
- Burkitt Lymphoma, Burkitt's Lymphoma, DNA Virus Infections, +18 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- New York Medical College Valhalla, New York, United States
- Levine Children's Hospital Charlotte, North Carolina, United States
- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
NCT02013128
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
- Locations
-
- TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
- TG Therapeutics Investigational Trial Site Tucson, Arizona, United States
- TG Therapeutics Investigational Trial Site Santa Barbara, California, United States
- TG Therapeutics Investigational Trial Site Boulder, Colorado, United States
NCT03349281
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Miami Miami, Florida, United States
Completed
Therapy for Pediatric Hodgkin Lymphoma
NCT00145600
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- Stanford University Palo Alto, California, United States
- Maine Children's Cancer Program Portland, Maine, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT02164955
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Cliniques Universitaires Saint Luc Brussels, Avenue Hippocrate 10, Belgium
- Ziekenhuis Netwerk Antwerpen- Campus Middelheim Antwerp, Lindendreef 1, Belgium
- Az Nikolaas Sint-Niklaas, Lodewijk de Meesterstraat 5, Belgium
- Centre Hospitalier Peltzer-La Tourelle Verviers, Rue Du Parc 29, Belgium
NCT02535286
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- TG Therapeutics Investigational Trial Site New York, United States
- TG Therapeutics Investigational Trial Site Durham, North Carolina, United States
- TG Therapeutics Investigational Trial Site Philadelphia, Pennsylvania, United States
- TG Therapeutics Investigational Trial Site Seattle, Washington, United States